End-of-day quote
Korea S.E.
2026-04-14
5-day change
1st Jan Change
1,440.00 KRW
+3.97%
+5.34%
-44.62%
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm Published on 06/17/2021
S&P Capital IQ
On June 18, 2021, Abpro Bio Co., Ltd. (KOSDAQ:A195990) closed the transaction.
Mar. 30
Abpro Bio Co., Ltd. announced that it has received KRW 3.9999998 billion in funding
CI
Mar. 15
Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding
CI
Mar. 15
Abpro Bio Co., Ltd. announced that it expects to receive KRW 3 billion in funding
CI
Mar. 12
Abpro Bio Co., Ltd. announced that it expects to receive KRW 3.999999824 billion in funding
CI
25-10-01
Investors left reading tea leaves
25-08-25
Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index
CI
24-06-16
Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.
CI
24-06-12
Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.
CI
23-05-15
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
22-12-15
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.
CI
22-09-25
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.
CI
21-12-23
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
21-10-13
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
CI
21-06-17
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
21-06-15
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions